Showing 3,641 - 3,660 results of 6,719 for search '"Diabetes"', query time: 0.08s Refine Results
  1. 3641
  2. 3642
  3. 3643
  4. 3644
  5. 3645

    102 Jurnal Kesehatan Andalas. 2015; 4(1) Pola Komplikasi Kronis Penderita Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS.... by Dwi Amelisa Edwina, Asman Manaf, Efrida .

    Published 2015-01-01
    “…<p>Abstrak<br />Diabetes Melitus (DM) merupakan suatu kelompok penyakit metabolik dengan karakteristik hiperglikemia. …”
    Get full text
    Article
  6. 3646
  7. 3647

    Area deprivation index predicts annual chronic kidney disease screening and chronic kidney disease development among patients with newly diagnosed hypertension and type 2 diabetes in a large midwestern health system: a retrospective cohort study by Rasha Khatib, Todd Williamson, Rakesh Singh, Mary Ingle, Yuxian Du, Vesta Valuckaite, Sheldon Kong, Sarang Baman

    Published 2024-04-01
    “…Background We explore how area deprivation index (ADI), a national ranking of neighbourhood sociodemographic disadvantage is associated with chronic kidney disease (CKD) screening and development among patients with newly diagnosed hypertension (HTN) or type 2 diabetes (T2DM).Methods Patients (n=235 208) with a new HTN or T2DM diagnosis between 2015 and 2018 in a large healthcare system were followed for 3 years to evaluate CKD screening (one estimated glomerular filtration rate and urinary albumin-to-creatine ratio) and CKD development. …”
    Get full text
    Article
  8. 3648
  9. 3649
  10. 3650
  11. 3651
  12. 3652
  13. 3653
  14. 3654
  15. 3655
  16. 3656
  17. 3657
  18. 3658
  19. 3659

    Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report by Yuya Fujita, Masao Nawata, Atsushi Nagayasu, Kazuki Someya, Kazuyoshi Saito, Yoshiya Tanaka

    Published 2019-01-01
    “…To date, no studies have demonstrated the effectiveness of baricitinib on systemic sclerosis or type 1 diabetes. We report that baricitinib was effective for systemic sclerosis and type 1 diabetes, as well as for rheumatoid arthritis, for up to 52 weeks.…”
    Get full text
    Article
  20. 3660